Vanguard Group Inc Trevena Inc Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.2 - $0.5 $195,266 - $488,166	976,333 Added 13.8%	8,052,551 $3.33 Million
Q1 2022 May 13, 2022	SELL	$0.41 - $0.63 $306,421 - $470,842	-747,369 Reduced 9.55%	7,076,218 $3.89 Million
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $19,048 - $43,110	33,419 Added 0.43%	7,823,587 $4.56 Million
Q3 2021 Nov 12, 2021	BUY	$1.11 - $1.7 $103,245 - $158,123	93,014 Added 1.21%	7,790,168 $9.58 Million
Q2 2021 Aug 13, 2021	BUY	$1.46 - $2.25 $11.2 Million - $17.3 Million	7,697,154 New	7,697,154 $13 Million

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.